19th May 2006
The Institute of Cancer Research is delighted to announce that David Barford, Professor of Molecular Biology and Co-Chairman of the Section of Structural Biology, has been elected to the Fellowship of the Royal Society.
This is the highest honour in the British scientific system and is a great tribute to Professor Barford's outstanding research into the mechanisms which control the growth of cells. It is failures in these mechanisms which underlie cancer and Professor Barford's work has greatly influenced the development of new anti-cancer drugs.
Professor Peter Rigby, Chief Executive of The Institute of Cancer Research, commented: “Professor Barford’s work has had a profound influence on our knowledge of cell growth which has been integral to the development of new cancer treatments. This outstanding achievement is a tribute to the quality of Professor Barford’s research and his Fellowship is an honour for The Institute of Cancer Research.”
- ends -
For further information or to arrange an interview, please contact:
The Institute of Cancer Research press office
Tel: 020 7153 5359 / 07788 427 856
Email: [email protected]
Notes to editors:
The Institute of Cancer Research
- The Institute of Cancer Research is Europe’s leading cancer research centre with expert scientists working on cutting edge research. It was founded in 1909 to carry out research into the causes of cancer and to develop new strategies for its prevention, diagnosis, treatment and care. Website at: www.icr.ac.uk
- The Institute works in a unique partnership with The Royal Marsden NHS Foundation Trust, forming the largest comprehensive cancer centre in Europe. This relationship enables close daily contact with those on the frontline in the fight against cancer - the clinicians, the carers and most importantly, the patients.
- The Institute is a charity that relies on voluntary income. The Institute is one of the world’s most cost-effective major cancer research organisations with over 90p in every £ directly supporting research.